Literature DB >> 14532213

Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci.

K R Fiebelkorn1, S A Crawford, M L McElmeel, J H Jorgensen.   

Abstract

Resistance to macrolides in staphylococci may be due to active efflux (encoded by msrA) or ribosomal target modification (macrolide-lincosamide-streptogramin B [MLSB] resistance; usually encoded by ermA or ermC). MLSB resistance is either constitutive or inducible following exposure to a macrolide. Induction tests utilize closely approximated erythromycin and clindamycin disks; the flattening of the clindamycin zone adjacent to the erythromycin disk indicates inducible MLSB resistance. The present study reassessed the reliability of placing erythromycin and clindamycin disks in adjacent positions (26 to 28 mm apart) in a standard disk dispenser, compared to distances of 15 or 20 mm. A group of 130 clinical isolates of Staphylococcus aureus and 100 isolates of erythromycin-resistant coagulase-negative staphylococci (CNS) were examined by disk approximation; all CNS isolates and a subset of S. aureus isolates were examined by PCR for ermA, ermC, and msrA. Of 114 erythromycin-resistant S. aureus isolates, 39 demonstrated constitutive resistance to clindamycin, while 33 showed inducible resistance by disk approximation at all three distances. Only one isolate failed to clearly demonstrate induction at 26 mm. Of 82 erythromycin-resistant CNS isolates that contained ermA or ermC, 57 demonstrated constitutive clindamycin resistance, and 25 demonstrated inducible resistance, at 20 and 26 mm. None of the 42 S. aureus isolates or 18 CNS isolates containing only msrA and none of the erythromycin-susceptible isolates yielded positive disk approximation tests. Simple placement of erythromycin and clindamycin disks at a distance achieved with a standard disk dispenser allowed detection of 97% of S. aureus strains and 100% of CNS strains with inducible MLSB resistance in this study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532213      PMCID: PMC254362          DOI: 10.1128/JCM.41.10.4740-4744.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Low level resistance to oleandomycin as a marker of ermA in staphylococci.

Authors:  Vicenza Di Modugno; Massimo Guerrini; Saroj Shah; Jeremy Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

2.  Relapse of staphylococcal endocarditis after clindamycin therapy.

Authors:  C U Tuazon; J N Sheagren
Journal:  Am J Med Sci       Date:  1975 Jan-Feb       Impact factor: 2.378

3.  A Staphylococcus aureus plasmid that specifies constitutive macrolide-lincosamide-streptogramin B resistance contains a novel deletion in the ermC attenuator.

Authors:  I Catchpole; K G Dyke
Journal:  FEMS Microbiol Lett       Date:  1990-05       Impact factor: 2.742

4.  Resistance of Staphylococcus aureus to lincomycin, clinimycin, and erythromycin.

Authors:  R McGehee RF; F F Barre; M Finland
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

5.  Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci.

Authors:  W D Jenssen; S Thakker-Varia; D T Dubin; M P Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

6.  Molecular epidemiology of macrolides-lincosamides-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococci.

Authors:  S Thakker-Varia; W D Jenssen; L Moon-McDermott; M P Weinstein; D T Dubin
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

7.  Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis.

Authors:  J I Ross; A M Farrell; E A Eady; J H Cove; W J Cunliffe
Journal:  J Antimicrob Chemother       Date:  1989-12       Impact factor: 5.790

8.  Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved.

Authors:  B Weisblum; V Demohn
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

9.  Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin.

Authors:  C Watanakunakorn
Journal:  Am J Med       Date:  1976-03       Impact factor: 4.965

10.  Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children.

Authors:  Arthur L Frank; John F Marcinak; P Daisy Mangat; Joyce T Tjhio; Swathi Kelkar; Paul C Schreckenberger; John P Quinn
Journal:  Pediatr Infect Dis J       Date:  2002-06       Impact factor: 2.129

View more
  112 in total

1.  Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  Jose Cadena; Shalini Nair; Andres F Henao-Martinez; James H Jorgensen; Jan E Patterson; Pranavi V Sreeramoju
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing.

Authors:  J H Jorgensen; S A Crawford; M L McElmeel; K R Fiebelkorn
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

3.  Complete nucleotide sequence analysis of plasmids in strains of Staphylococcus aureus clone USA300 reveals a high level of identity among isolates with closely related core genome sequences.

Authors:  Adam D Kennedy; Stephen F Porcella; Craig Martens; Adeline R Whitney; Kevin R Braughton; Liang Chen; Carly T Craig; Fred C Tenover; Barry N Kreiswirth; James M Musser; Frank R DeLeo
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

4.  Incidence of inducible clindamycin resistance in Staphylococcus pseudintermedius from dogs.

Authors:  Randi M Gold; Sara D Lawhon
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

5.  Dissemination of community-acquired methicillin-resistant Staphylococcus aureus clones in northern Norway: sequence types 8 and 80 predominate.

Authors:  Anne-Merethe Hanssen; Aina Fossum; Jarle Mikalsen; Dag S Halvorsen; Geir Bukholm; Johanna U Ericson Sollid
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

6.  Dissemination of multisusceptible methicillin-resistant Staphylococcus aureus in Singapore.

Authors:  Li-Yang Hsu; Tse-Hsien Koh; Kamaljit Singh; Mei-Ling Kang; Asok Kurup; Ban-Hock Tan
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

7.  Selection of strains for quality assessment of the disk induction method for detection of inducible clindamycin resistance in Staphylococci: a CLSI collaborative study.

Authors:  Adrian M Zelazny; Mary Jane Ferraro; Anita Glennen; Janet F Hindler; Linda M Mann; Susan Munro; Patrick R Murray; L Barth Reller; Fred C Tenover; James H Jorgensen
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 8.  Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci.

Authors:  G M Eliopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

9.  Induction of telithromycin resistance by erythromycin in isolates of macrolide-resistant Staphylococcus spp.

Authors:  Kepler A Davis; Sharon A Crawford; Kristin R Fiebelkorn; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

10.  The prevalence of inducible clindamycin resistance among staphylococci in a tertiary care hospital - a study from the garhwal hills of uttarakhand, India.

Authors:  Deepak Juyal; A S Shamanth; Shekhar Pal; Munesh Kumar Sharma; Rajat Prakash; Neelam Sharma
Journal:  J Clin Diagn Res       Date:  2012-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.